CelLBxHealth plc Share Price
Stocks
CLBX
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.350 GBX | 0.00% |
|
+1.89% | +22.73% |
| 08-03 | Cellbxhealth plc Uses Parsortix Platform to Detect Adc-Relevant Targets on Circulating Tumour Cells from Breast and Ovarian Cancer Patients | CI |
| 07-15 | Beeks in "strong" year; Iofina output up | AN |
| Market Cap | 15.34M 20.74M 17.96M 16.79M 28.91M 1.98B 29.36M 197M 77.24M 990M 77.89M 76.19M 3.3B | P/E 2026 * |
-0.58x | P/E 2027 * | -15x |
|---|---|---|---|---|---|
| Enterprise Value | 13.74M 18.58M 16.09M 15.04M 25.89M 1.77B 26.3M 176M 69.18M 887M 69.77M 68.25M 2.95B | EV / Sales 2026 * |
0.63x | EV / Sales 2027 * | 0.44x |
| Free-Float |
94.31% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CelLBxHealth plc
| 16/10/25 | Angle names Peter Collins as interim CEO | AN |
| 28/05/25 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 23/01/25 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 14/09/23 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 24/01/22 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 week | +1.89% | ||
| Current month | +5.88% | ||
| 1 month | -1.82% | ||
| 3 months | +31.71% | ||
| 6 months | +28.57% | ||
| Current year | +22.73% |
| 1 week | 1.3 |  | 1.4 |
| 1 month | 1.2 | | 1.53 |
| Current year | 0.85 | | 2.8 |
| 1 year | 0.85 | | 8 |
| 3 years | 0.85 | | 37.4 |
| 5 years | 0.85 | | 163.75 |
| 10 years | 0.85 | | 163.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 31/12/1998 |
| Chief Tech/Sci/R&D Officer | - | 31/12/2024 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 04/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Groen
CHM | Chairman | 67 | 21/05/2023 |
Klaas de Boer
BRD | Director/Board Member | 61 | 11/01/2026 |
| Director/Board Member | 61 | 11/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Buy | Chief Executive Officer | 5,000,000 | 1.5497% | ||
| 19/12/25 | Buy | Chief Financial Officer | 2,500,000 | 0.7749% | ||
| 19/12/25 | Buy | Chairman | 5,000,000 | 1.5497% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +1.89% | -74.29% | -89.41% | 20.7M | |
| +2.76% | +5.95% | +31.82% | -35.16% | 16.86B | |
| -5.20% | -10.12% | -11.81% | +91.74% | 1.75B | |
| 0.00% | +2.96% | -29.08% | +24.78% | 1.01B | |
| +11.93% | -22.36% | -42.49% | -82.23% | 842M | |
| +0.44% | +2.32% | -36.69% | -50.98% | 679M | |
| +2.62% | +4.06% | -46.78% | -49.19% | 548M | |
| +48.75% | +54.87% | +94.73% | -14.89% | 523M | |
| -1.03% | +5.34% | -44.77% | -42.16% | 417M | |
| 0.00% | +2.97% | -7.97% | -23.99% | 384M | |
| Average | +6.03% | +3.86% | -16.73% | -27.15% | 2.3B | |
| Weighted average by Cap. | +3.22% | +3.47% | +18.52% | -24.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.65M 29.27M 25.34M 23.69M 40.8M 2.79B 41.44M 278M 109M 1.4B 110M 108M 4.65B | 37.75M 51.05M 44.19M 41.3M 71.14M 4.87B 72.25M 484M 190M 2.44B 192M 187M 8.11B |
| Net income | -8.55M -11.56M -10.01M -9.36M -16.11M -1.1B -16.36M -110M -43.05M -552M -43.41M -42.46M -1.84B | -1.85M -2.5M -2.17M -2.02M -3.49M -239M -3.54M -23.74M -9.31M -119M -9.39M -9.19M -398M |
| Net Debt | -1.6M -2.16M -1.87M -1.75M -3.02M -206M -3.06M -20.53M -8.06M -103M -8.12M -7.95M -344M | 1.4M 1.89M 1.64M 1.53M 2.64M 181M 2.68M 17.96M 7.05M 90.32M 7.11M 6.95M 301M |
Employees
114
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | GBX 1.350 | 0.00% | 1,343,703 |
| 07/08/26 | GBX 1.350 | 0.00% | 417,398 |
| 06/08/26 | GBX 1.350 | +1.89% | 5,909,513 |
| 05/08/26 | GBX 1.325 | 0.00% | 105,492 |
| 04/08/26 | GBX 1.325 | 0.00% | 1,212,826 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0135GBP
Average target price
0.0400GBP
Spread / Average Target
+196.30%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
Select your edition
All financial news and data tailored to specific country editions
